Cargando…
Mitochondrial metabolism as a target for acute myeloid leukemia treatment
Acute myeloid leukemias (AML) are a group of aggressive hematologic malignancies resulting from acquired genetic mutations in hematopoietic stem cells that affect patients of all ages. Despite decades of research, standard chemotherapy still remains ineffective for some AML subtypes and is often ina...
Autores principales: | Panina, Svetlana B., Pei, Jingqi, Kirienko, Natalia V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058979/ https://www.ncbi.nlm.nih.gov/pubmed/33883040 http://dx.doi.org/10.1186/s40170-021-00253-w |
Ejemplares similares
-
Utilizing Synergistic Potential of Mitochondria-Targeting Drugs for Leukemia Therapy
por: Panina, Svetlana B., et al.
Publicado: (2020) -
A mechanism for increased sensitivity of acute myeloid leukemia to mitotoxic drugs
por: Panina, Svetlana B., et al.
Publicado: (2019) -
Targeting Metabolic Reprogramming in Acute Myeloid Leukemia
por: Castro, Isabel, et al.
Publicado: (2019) -
Targeting mitochondrial RNA polymerase in acute myeloid leukemia
por: Bralha, Fernando N., et al.
Publicado: (2015) -
Metabolic Plasticity of Acute Myeloid Leukemia
por: Kreitz, Johanna, et al.
Publicado: (2019)